ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.526,27
1,51%
S&P 500
5.099,96
1,02%
US Dollar vs BRL
5,1163
0,00%
Bitcoin
63.791,95
0,60%
Brent Oil
88,165
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Tonix Pharmaceuticals Holding Corporation (TNXP)

  7. Tonix Pharmaceuticals Holding Corporation (TNXP) Notícias

TNXP Tonix Pharmaceuticals Holding Corporation

0,17
0,01005 (6,28%)
26 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Tonix Pharmaceuticals Holding Corporation TNXP NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,01005 6,28% 0,17 20:50:13
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,16 0,1597 0,1703 0,1685 0,15995
mais cotações »

Notícias Recentes

Data Hora Fonte Título
24/04/202409:00GLOBETonix Pharmaceuticals Announces Presentation at Planet..
01/04/202417:15GLOBETonix Pharmaceuticals Reports Fourth Quarter and Full Year..
28/03/202410:32GLOBETonix Pharmaceuticals Announces Pricing of $4.4 Million..
25/03/202409:00GLOBETonix Pharmaceuticals Receives Rare Pediatric Disease..
21/03/202409:00GLOBETonix Pharmaceuticals Announces Poster Presentation..
20/03/202409:00GLOBETonix Pharmaceuticals Announces Selection of Two Contract..
19/03/202409:00GLOBETonix Pharmaceuticals Announces Transition to Fully..
12/03/202409:00GLOBETonix Pharmaceuticals Announces Presentation at BIO-Europe..
11/03/202409:00GLOBETonix Pharmaceuticals Reports Improvement in “Brain Fog,” in..
07/03/202411:37GLOBENew to The Street Announces TV Episode 560 with its Five..
07/03/202410:00GLOBETonix Pharmaceuticals Announces Publication in Psychiatry..
06/03/202410:00GLOBETonix Pharmaceuticals Selects EVERSANA® to Support Launch..
05/03/202410:00GLOBETonix Pharmaceuticals Announces Translation of Preclinical..
29/02/202410:00GLOBETonix Pharmaceuticals Announces Presentation at The 6th..
28/02/202410:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 1..
27/02/202410:00GLOBETonix Pharmaceuticals Announces Positive Results from..
23/02/202411:30GLOBENew to The Street Announces Line-up of its Corporate..
20/02/202410:00GLOBETonix Pharmaceuticals to Participate in the 2024 BIO CEO &..
16/02/202411:30GLOBENew to The Street Airs Episode 556 Featuring Five Corporate..
14/02/202410:00GLOBETonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3..
13/02/202410:00GLOBETonix Pharmaceuticals Announces Engagement of Rho as CRO to..
12/02/202410:00GLOBETonix Pharmaceuticals Announces FDA IND Clearance for DoD..
31/01/202409:00GLOBETonix Pharmaceuticals Announces Research Indicating..
29/01/202409:00GLOBETonix Pharmaceuticals Announces Conditional Acceptance of..
25/01/202409:00GLOBETonix Pharmaceuticals Announces KOL Webinar to Discuss..
09/01/202409:00GLOBETonix Pharmaceuticals Presents Additional Data Highlighting..
03/01/202409:00GLOBETonix Pharmaceuticals to Present at Two Upcoming Investor..
20/12/202312:35GLOBETonix Pharmaceuticals Announces Registered Direct Offering..
20/12/202312:30GLOBETonix Pharmaceuticals Announces Highly Statistically..
11/12/202309:00GLOBETonix Pharmaceuticals to Present at The National Academies..
04/12/202309:00GLOBETonix Pharmaceuticals Announces IND Clearance by the FDA for..
28/11/202309:00GLOBETonix Pharmaceuticals to Present at Two Upcoming Investor..
15/11/202309:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 3..
13/11/202309:00GLOBETonix Pharmaceuticals Announces Enrollment Initiated in Mass..
09/11/202318:15GLOBETonix Pharmaceuticals Reports Third Quarter 2023 Financial..
02/11/202309:00GLOBETonix Pharmaceuticals’ Vaccine Candidate, TNX-1800, Selected..
31/10/202318:00GLOBETonix Pharmaceuticals Announces Topline Results from Phase 2..
30/10/202308:00GLOBETonix Pharmaceuticals Announces New Data Involving TNX-1500..
26/10/202308:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 2..
18/10/202308:00GLOBETonix Pharmaceuticals Announces Publication of Data in the..
16/10/202308:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 2..
12/10/202308:00GLOBETonix Pharmaceuticals to Present at the 2023 ThinkEquity..
11/10/202308:00GLOBETonix Pharmaceuticals Announces Oral Presentation at the..
09/10/202308:00GLOBETonix Pharmaceuticals Provides Overview of TNX-2900 Program..
04/10/202308:00GLOBETonix Pharmaceuticals Announces Issuance of EU Patent..
28/09/202322:00GLOBETonix Pharmaceuticals Announces Pricing of $4.5 Million..
28/09/202317:01GLOBETonix Pharmaceuticals Announces Proposed Public Offering
27/09/202309:30GLOBETonix Pharmaceuticals Announces Department of Defense Grant..
21/09/202308:00GLOBETonix Pharmaceuticals Presents New Preclinical Data at..
18/09/202308:00GLOBETonix Pharmaceuticals Announces Presentation of Non-Clinical..

Seu Histórico Recente

NASDAQ
TNXP
Tonix Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados